A novel gene, GCRG224, is differentially expressed in human gastric mucosa

World Journal of Gastroenterology

Volumn 9, Issue 1, 2003, Pages 30-34

  Wang, Gang Shi ^a   Wang, Meng Wei ^a   Wu, Ben Yan ^a   You, Wei Di ^a   Yang, Xin Yan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DIGOXIGENIN; PARAFFIN;

ADULT; AGED; ARTICLE; CHROMOSOME 114Q14; CHROMOSOME 11Q; CLINICAL ARTICLE; COLON; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DYSPLASIA; FEMALE; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE SEQUENCE; GENETIC DATABASE; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE METAPLASIA; LEUKOCYTE; MALE; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROBE; SEQUENCE HOMOLOGY; STOMACH; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; STOMACH CANCER; STOMACH GLAND; STOMACH MUCOSA; TUMOR;

EID: 0037439090     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i1.30     Document Type: Article

References (57)

1. Stadtlander CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 1999; 20: 2195-2208
2. Becker KF, Keller G, Hoefler H. The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 2000; 9: 5-11
3. Boussioutas A, Taupin D. Towards a molecular approach to gastric cancer management. Intern Med J 2001; 31: 296-303
4. Palli D. Epidemiology of gastric cancer: An evaluation of available evidence. J Gastroenterol 2000; 35(Suppl 12): 84-89
5. Yasui W, Oue N, Kuniyasu H, Ito H, Tahara E, Yokozaki H. Molecular diagnosis of gastric cancer: Present and future. Gastric Cancer 2001; 4: 113-121
6. Maltoni M, Volpi A, Nanni O, Bajorko P, Belletti E, Vecci AM, Liverani M, Danesi S, Calistri D, Ricotti L, Amadori D. Gastric cancer: Epidemiologic and biological aspects. Forum (Genova) 1998; 8: 199-207
7. Meltzer SJ. Tumor genomics vs. tumor genetics: A paradigm shift? Gastroenterology 2001; 121: 726-729
8. Wang GS, Wang MW, You WD, Wang HF, Feng MF. Fluorescent mRNA differential display technique. Zhongguo Yingyong Shenglixue Zazhi 2000; 16: 373-376
9. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-3402
10. Komminoth P, Merk FB, Leav I, Wolfe HJ, Roth J. Comparison of 35S- and digoxigenin-labeled RNA and oligonucleotide probes for In situ hybridization. Expression of mRNA of the seminal vesicle secretion protein II and androgen receptor genes in the rat prostate. Histochemistry 1992; 98: 217-228
11. Komminoth P. Digoxigenin as an alternative probe labeling for In situ hybridization. Diagn Mol Pathol 1992; 1: 142-150
12. Kubicka S, Claas C, Staab S, Kuhnel F, Zender L, Trautwein C, Wagner S, Rudolph KL, Manns M. p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: Relation to histological subtypes, Helicobacter pylori infection, and prognosis. Dig Dis Sci 2002; 47: 114-121
13. Hiyama T, Haruma K, Kitadai Y, Masuda H, Miyamoto M, Tanaka S, Yoshihara M, Shimamoto F, Chayama K. K-ras mutation in helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer 2002; 97: 562-566
14. Yokozaki H, Yasui W, Tahara E. Genetic and epigenetic changes in stomach cancer. Int Rev Cytol 2001; 204: 49-95
15. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, Nakano H. The prognostic significance of amplification and overexpression of c-met and c-erbB-2 in human gastric carcinomas. Cancer 1999; 85: 1894-1902
16. Gurel S, Dolar E, Yerci O, Samli B, Ozturk H, Nak SG, Gulten M, Memik F. The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer. J Int Med Res 1999; 27: 74-78
17. Gurel S, Dolar E, Samli B, Ozturk H, Nak SG, Gulten M, Memik F. Expression of p53 protein and prognosis in gastric carcinoma. J Int Med Res 1999; 27: 85-89
18. Sato K, Tamura G, Tsuchiya T, Endoh Y, Usuba O, Kimura W, Motoyama T. Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer. Br J Cancer 2001; 85: 199-203
19. He XS, Su Q, Chen ZC, He XT, Long ZF, Ling H, Zhang LR. Expression, deletion and mutation of p16 gene in human gastric cancer. World J Gastroenterol 2001; 7: 515-521
20. Liu DH, Zhang XY, Fan DM, Huang YX, Zhang JS, Huang WQ, Zhang YQ, Huang QS, Ma WY, Chai YB, Jin M. Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma. World J Gastroenterol 2001; 7: 500-505
21. Liu XP, Tsushimi K, Tsushimi M, Kawauchi S, Oga A, Furuya T, Sasaki K. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: Its relationships with cell proliferation activity and prognosis. Cancer Lett 2001; 170: 183-189
22. Fei G, Ebert MP, Mawrin C, Leodolter A, Schmidt N, Dietzmann K, Malfertheiner P. Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives. Eur J Gastroenterol Hepatol 2002; 14: 297-303
23. Kang YH, Lee HS, Kim WH. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest 2002; 82: 285-291
24. Ebert MP, Fei G, Kahmann S, Muller O, Yu J, Sung JJ, Malfertheiner P. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 2002; 23: 87-91
25. Laghi L, Ranzani GN, Bianchi P, Mori A, Heinimann K, Orbetegli O, Spaudo MR, Luinetti O, Francisconi S, Roncalli M, Solcia E, Malesci A. Frameshift mutations of human gastrin receptor gene (hGARE) in gastrointestinal cancers with microsatellite instability. Lab Invest 2002; 82: 265-271
26. Sakata K, Tamura G, Endoh Y, Ohmura K, Ogata S, Motoyama T. Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability. Br J Cancer 2002; 86: 564-567
27. Baba H, Korenaga D, Kakeji Y, Haraguchi M, Okamura T, Maehara Y. DNA ploidy and its clinical implications in gastric cancer. Surgery 2002; 131 (Suppl): S63-70
28. Russo A, Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Latteri F, Valerio MR, Pantuso G, Morello V, Dardanoni G, Latteri MA, Colucci G, Tomasino RM, Gebbia N. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma; Results of a 5-year gruppo oncologico dell'italia meridonale prospective study. Cancer 2001; 92: 294-302
29. Nesi G, Palli D, Pernice LM, Saieva C, Paglierani M, Kroning KC, Catarzi S, Rubio CA, Amorosi A. Expression of nm23 gene in gastric cancer is associated with a poor 5-year survival. Anticancer Res 2001; 21: 3643-3649
30. Cai J, Ikeguchi M, Tsujitani S, Maeta M, Liu J, Kaibara N. Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. Gastric Cancer 2001; 4: 66-74
31. Van Rees BP, Saukkonen K, Ristimaki A, Polkowski W, Tytgat GN, Drillenburg P, Offerhaus GJ. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J Pathol 2002; 196: 171-179
32. Kikuchi T, Itoh F, Toyota M, Suzuki H, Yamamoto H, Fujita M, Hosokawa M, Imai K. Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. Int J Cancer 2002; 97: 272-277
33. Krieg A, Mahotka C, Krieg T, Grabsch H, Muller W, Takeno S, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD. Expression of different survivin variants in gastric carcinomas: First clues to a role of survivin-2B in tumour progression. Br J Cancer 2002; 86: 737-743
34. Ebert MP, Gunther T, Hoffmann J, Yu J, Miehlke S, Schulz HU, Roessner A, Korc M, Malfertheiner P. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res 2000; 60: 1995-2001
35. Bai YQ, Yamamoto H, Akiyama Y, Tanaka H, Takizawa T, Koike M, Kenji Yagi O, Saitoh K, Takeshita K, Iwai T, Yuasa Y. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett 2002; 176: 47-55
36. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113-124
37. Saitoh T, Mine T, Katoh M. Up-regulation of WNT8B mRNA in human gastric cancer. Int J Oncol 2002; 20: 343-348
38. Li Z, Wang Y, Song J, Kataoka H, Yoshii S, Gao C, Wang Y, Zhou J, Ota S, Tanaka M, Sugimura H. Genomic structure of the human beta-PIX gene and its alteration in gastric cancer. Cancer Lett 2002; 177: 203-208
39. Shinohara H, Morita S, Kawai M, Miyamoto A, Sonoda T, Pastan I, Tanigawa M. Expression of HER2 in human gastric cancer cells directly correlates with antitumor activity of a recombinant disulfide-stabilized anti-HER2 immunotoxin. J Surg Res 2002; 102: 169-177
40. Takehana T, Kunitomo K, Kono K, Kitahara F, Iizuka H, Matsumoto Y, Fujino MA, Ooi A. Status of c-erbB-2 in gastric adenocarcinoma: A comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immunosorbent assay. Int J Cancer 2002; 98: 833-837
41. Kodera Y, Nakanishi H, Ito S, Yamamura Y, Kanemitsu Y, Shimizu Y, Hirai T, Yasui K, Kato T, Tatematsu M. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: A sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg 2002; 235: 499-506
42. You H, Xiao B, Cui DX, Shi YQ, Fan DM. Two novel gastric cancer-associated genes identified by differential display. World J Gastroenterol 1998; 4: 334-336
43. Tortola S, Marcuello E, Risques RA, Gonzalez S, Aiza G, Capella G, Peinado MA. Overall deregulation in gene expression as a novel indicator of tumor aggressiveness in colorectal cancer. Oncogene 1999; 18: 4383-4387
44. Yoshikawa Y, Mukai H, Hino F, Asada K, Kato I. Isolation of two novel genes, down-regulated in gastric cancer. Jan J Cancer Res 2000; 91: 459-463
45. Wang X, Lan M, Shi YQ, Lu J, Zhong YX, Wu HP, Zai HH, Ding J, Wu KC, Pan BR, Jin JP, Fan DM. Differential display of vincristine-resistance-related genes in gastric cancer SGC7901 cell. World J Gastroenterol 2002; 8: 54-59
46. Shiozaki K, Nakamori S, Tsujie M, Okami J, Yamamoto H, Nagano H, Dono K, Umeshita K, Sakon M, Furukawa H, Hiratsuka M, Kasugai T, Ishiguro S, Monden M. Human stomach-specific gene, CA11, is down-regulated in gastric cancer. Int J Onco 2001; 19: 701-707
47. Wang G, Wang M, You W, Li H. Cloning and primary expression analyses of down-regulated cDNA fragment in human gastric cancer. Zhonghua Yixue Yichuanxue Zazhi 2001; 18: 43-47
48. Fend F, Kremer M, Quintanilla-Martinez L. Laser capture microdissection: Methodical aspects and applications with emphasis on immuno-laser capture microdissection. Pathobiology 2000; 68: 209-214
49. Maitra A, Wistuba II, Gazdar AF. Microdissection and the study of cancer pathways. Curr Mol Med 2001; 1: 153-162
50. Rekhter MD, Chen J. Molecular analysis of complex tissues is facilitated by laser capture microdissection: Critical role of upstream tissue processing. Cell Biochem Biophys 2001; 35: 103-113
51. Cor A, Vogt N, Malfoy B. Microdissection techniques for cancer analysis. Folia Biol (Praha) 2002; 48: 3-8
52. Noda H, Maehara Y, Irie K, Kakeji Y, Yonemura T, Sugimachi K. Increased proliferative activity caused by loss of p21WAF1/CIP1 expression and its clinical significance in patients with early-stage gastric carcinoma. Cancer 2002; 94: 2107-2112
53. Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett 2001; 169: 21-26
54. Kuniyasu H, Oue N, Wakikawa A, Shigeishi H, Matsutani N, Kuraoka K, Ito R, Yokozaki H, Yasui W. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 2002; 196: 163-170.
55. Mori M, Mimori K, Yoshikawa Y, Shibuta K, Utsunomiya T, Sadanaga N, Tanaka F, Matsuyama A, Inoue H, Sugimachi K. Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 2002; 131: S39-47
56. Endo K, Maejara U, Baba H, Tokunaga E, Koga T, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Nakajima M, Sugimachi K. Heparanase gene expression and metastatic potential in human gastric cancer. Anticancer Res 2001; 21: 3365-3369
57. Wang CS, Lin KH, Hsu YC. Alterations of thyroid hormone receptor alpha gene: Frequency and association with Nm23 protein expression and metastasis in gastric cancer. Cancer Lett 2002; 175: 121-127